These findings are consistent with other studies observing elevated baseline HbA1c levels in the group that initiated insulin.13,20,37 This emphasises the importance of glycaemic control shortly after commencing treatment with metformin in predicting treatment trajectory and diabetes progression in individuals with T2DM. Here, INS is linked to type 2 diabetes mellitus.